Χώρα: Μάλτα
Γλώσσα: Αγγλικά
Πηγή: Malta Medicines Authority
diclofenac sodium 50 mg
Novartis Pharmaceuticals UK Limited
M01AB05
diclofenac sodium
dispersible tablet
Authorised
2005-10-25
VOLTAREN® D DISPERSIBLE TABLETS 50MG (DICLOFENAC SODIUM) PATIENT INFORMATION LEAFLET WHAT YOU NEED TO KNOW ABOUT VOLTAREN DISPERSABLE TABLETS Your doctor has decided that you need this medicine to help treat your condition. PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKE YOUR MEDICINE. IT CONTAINS IMPORTANT INFORMATION. Keep this leaflet in a safe place because you may want to read it again. If you have any other questions, or if there is something you don’t understand, please ask your doctor or pharmacist. This medicine has been prescribed for you. Never give it to someone else. It may not be the right medicine for them even if their symptoms seem to be the same as yours. If any of the side effects affects you severely, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET 1 WHAT VOLTAREN ® DISPERSIBLE TABLETS ARE, AND WHAT THEY ARE USED FOR 2 THINGS TO CONSIDER BEFORE YOU START TO TAKE VOLTAREN ® DISPERSIBLE TABLETS 3 HOW TO TAKE VOLTAREN DISPERSIBLE TABLETS 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE VOLTAREN DISPERSIBLE TABLETS 6 FURTHER INFORMATION 1. WHAT VOLTAREN DISPERSIBLE TABLETS ARE AND WHAT THEY ARE USED FOR Diclofenac sodium, the active ingredient of Voltaren dispersible tablets, is one of a group of medicines called “non-steroidal anti-inflammatory drugs” (NSAIDs). NSAIDs reduce pain and inflammation inflammation, by blocking the synthesis of the molecules (prostoglandins) responsible for inflammation, pain and fever. Voltaren Dispersible Tablets act quickly and so are used to treat short term painful conditions affecting the joints and muscles. They are especially useful for the treatment Διαβάστε το πλήρες έγγραφο
Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT VOLTAREN ® D 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The active substance is [o[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (= diclofenac free acid). One Voltaren ® D dispersible tablet contains 46.5 mg of diclofenac free acid, which is equivalent to 50 mg of diclofenac sodium. 3 PHARMACEUTICAL FORM Dispersible tablets, specifically designed to disintegrate quickly in water, yielding a tasteless suspension of diclofenac free acid. The suspension is to be taken orally. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Short-term treatment of the following acute conditions: Symptomatic, short-term treatment of post-operative inflammation and pain (POP), e.g. following dental or orthopedic surgery. Painful post-traumatic inflammatory states, e.g. due to sprains. Flare-up of osteoarthritis. Acute attacks of gout. Non-articular rheumatism. Painful syndromes of the vertebral column. Painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhea or adnexitis. Symptomatic short-term treatment of pain related to inflammatory infections of the ear, nose or throat, e.g. pharyngotonsillitis, otitis (ENT). In keeping with general therapeutic principles, the underlying disease should be treated with anti-infective basic therapy, as therapeutically appropriate. Fever alone without inflammatory component is not an indication. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION As a general recommendation, the dose should be individually adjusted and the lowest effective dose given for the shortest possible duration. Undesirable effects may be minimised by using the lowes Διαβάστε το πλήρες έγγραφο